WHO ICTRP trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group…
ChiCTR2500107905 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500107905 |
|---|---|
| Public title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial to Evaluate the Efficacy and Safety of TQC2731 Injection in Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) |
| Scientific title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial to Evaluate the Efficacy and Safety of TQC2731 Injection in Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) |
| Primary sponsor | Eye & ENT hospital of Fudan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 3 |
| Countries | China |
| Conditions | Bilateral chronic rhinosinusitis with nasal polyps (CRSwNP) |
| Interventions | Experimental group:Using mometasone furoate nasal spray as background medication for treatment;control group:Using mometasone furoate nasal spray as background medication for treatment |
| Registration date | Aug 20, 2025 |
| Target size | Experimental group:100;control group:100 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: